Literature DB >> 30573176

Population Shift Mechanism for Partial Agonism of AMPA Receptor.

Hiraku Oshima1, Suyong Re1, Masayoshi Sakakura2, Hideo Takahashi2, Yuji Sugita3.   

Abstract

α-amino-3-hydroxy-5-methyl-4-isoaxazolepropionic acid (AMPA) ionotropic glutamate receptors mediate fast excitatory neurotransmission in the central nervous system, and their dysfunction is associated with neurological diseases. Glutamate binding to ligand-binding domains (LBDs) of AMPA receptors induces channel opening in the transmembrane domains of the receptors. The T686A mutation reduces glutamate efficacy so that the glutamate behaves as a partial agonist. The crystal structures of wild-type and mutant LBDs are very similar and cannot account for the observed behavior. To elucidate the molecular mechanism inducing partial agonism of the T686A mutant, we computed the free-energy landscapes governing GluA2 LBD closure using replica-exchange umbrella sampling simulations. A semiclosed state, not observed in crystal structures, appears in the mutant during simulation. In this state, the LBD cleft opens slightly because of breaking of interlobe hydrogen bonds, reducing the efficiency of channel opening. The energy difference between the LBD closed and semiclosed states is small, and transitions between the two states would occur by thermal fluctuations. Evidently, glutamate binding to the T686A mutant induces a population shift from a closed to a semiclosed state, explaining the partial agonism in the AMPA receptor.
Copyright © 2018 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30573176      PMCID: PMC6342705          DOI: 10.1016/j.bpj.2018.11.3122

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  39 in total

1.  Characterizing single-channel behavior of GluA3 receptors.

Authors:  Kinning Poon; Linda M Nowak; Robert E Oswald
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution.

Authors:  Alexander S Maltsev; Ahmed H Ahmed; Michael K Fenwick; David E Jane; Robert E Oswald
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

4.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

5.  The cell biology of synaptic plasticity.

Authors:  Victoria M Ho; Ji-Ann Lee; Kelsey C Martin
Journal:  Science       Date:  2011-11-04       Impact factor: 47.728

Review 6.  AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.

Authors:  Philip K-Y Chang; David Verbich; R Anne McKinney
Journal:  Eur J Neurosci       Date:  2012-06       Impact factor: 3.386

7.  AMPA receptor binding cleft mutations that alter affinity, efficacy, and recovery from desensitization.

Authors:  Antoine Robert; Neali Armstrong; J Eric Gouaux; James R Howe
Journal:  J Neurosci       Date:  2005-04-13       Impact factor: 6.167

8.  Interplay between structural rigidity and electrostatic interactions in the ligand binding domain of GluR2.

Authors:  Tatyana Mamonova; Kirill Speranskiy; Maria Kurnikova
Journal:  Proteins       Date:  2008-11-15

9.  Structural Mechanisms of Gating in Ionotropic Glutamate Receptors.

Authors:  Edward C Twomey; Alexander I Sobolevsky
Journal:  Biochemistry       Date:  2017-10-27       Impact factor: 3.162

10.  Neurotransmitter Funneling Optimizes Glutamate Receptor Kinetics.

Authors:  Alvin Yu; Héctor Salazar; Andrew J R Plested; Albert Y Lau
Journal:  Neuron       Date:  2017-12-14       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.